| HAIPENG, YU |
NCT06484764: Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Biopsy Procedure. |
|
|
| Completed | N/A | 166 | RoW | CT-fluoroscopy guided robot-assisted biopsy of thoracic and abdominal lesions, Freehand CT-guided percutaneous needle biopsy of thoracic and abdominal lesions | Tianjin Medical University Cancer Institute and Hospital, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Wuhan United Imaging Healthcare-Surgical Technology Co., Ltd. Wuhan, China | Abdominal Cancer, Thoracic Cancer | 10/23 | 11/23 | | |
| Li, Kai |
NCT04448873: Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma |
|
|
| Completed | 4 | 30 | RoW | Sirolimus, Rapamycin | Children's Hospital of Fudan University | Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome | 02/23 | 07/23 | | |
NCT04921722: Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies |
|
|
| Recruiting | 4 | 75 | RoW | Percutaneous sirolimus, Rapamycin, Oral sirolimus | Children's Hospital of Fudan University | Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies, Superficial Lymphatic Malformations | 11/25 | 11/25 | | |
TQB2450-III-09, NCT04964479: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) |
|
|
| Recruiting | 3 | 375 | RoW | TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection, Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 12/22 | 03/23 | | |
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis |
|
|
| Recruiting | 3 | 688 | RoW | Radical colectomy, HIPEC, Systemic chemotherapy | Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University | Colorectal Cancer | 04/24 | 04/26 | | |
NCT04412564: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor |
|
|
| Recruiting | 2 | 200 | RoW | TQ-B3101 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Malignant Tumor | 03/21 | 09/21 | | |
TQB2450-ALTN-II-02, NCT06141226: Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 148 | RoW | TQB2450 +Anlotinib+Docetaxel, TQB2450/Anlotinib/Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel, TQB2450/Anlotinib Placebo/Docetaxel | Tianjin Medical University Cancer Institute and Hospital | Non-small-cell Lung Cancer | 12/27 | 12/28 | | |
| Recruiting | N/A | 30000 | RoW | | Beijing Jishuitan Hospital, Chinese PLA General Hospital, Ruijin Hospital, Huashan Hospital, Henan Provincial People's Hospital, The Affiliated Hospital Of Guizhou Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital Xi'an Jiaotong University, The renmin hospital of wuhan university, Nanjing BenQ Hospital, China-Japan Friendship Hospital, xinan hospital, Wu Hu Yijishan hospital, The fifth affiliated hospital of zhong shan university | Osteoporosis, Obesity, Liver Steatoses | 06/23 | 12/23 | | |
NCT06637215: Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer |
|
|
| Recruiting | N/A | 352 | RoW | laparoscopic colorectal day surgery, traditional laparoscopic colorectal surgery | First Hospital of China Medical University | Colorectal Carcinoma, Day Surgery | 03/26 | 03/29 | | |
| Recruiting | N/A | 80 | RoW | Tight pressure management, Routine pressure management | The Cleveland Clinic | General Surgery | 12/24 | 06/25 | | |
| Recruiting | N/A | 6254 | Europe, Japan, US, RoW | Tight pressure management, Routine pressure management | The Cleveland Clinic | Blood Pressure | 12/26 | 04/27 | | |
NCT05351216: The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma |
|
|
| Recruiting | N/A | 174 | RoW | | Children's Hospital of Fudan University | Kaposiform Hemangioendothelioma | 03/26 | 03/28 | | |
NCT06059560: Nutritional Intervention for Patients With Multiple Cancer Types |
|
|
| Recruiting | N/A | 1000 | RoW | Nutritional therapy | First Hospital of China Medical University | Cancer | 10/26 | 10/26 | | |
NCT05001321: Multi-center and Multi-modal Deep Learning Study of Gastric Cancer |
|
|
| Active, not recruiting | N/A | 3300 | RoW | The whole abdomen contrast-enhanced CT scan, H&E stained sections and slides | First Hospital of China Medical University, The Second Hospital of Shandong University, Chaoyang Central Hospital, The General Hospital of Fushun Mining Bureau, The fourth People's Hospital of Changzhou, First Hospital of Jinzhou Medical University | Stomach Neoplasms | 01/22 | 12/24 | | |
| Recruiting | N/A | 200 | RoW | CTC test, ctDNA test | First Hospital of China Medical University | Stomach Neoplasms, Metastasis | 02/23 | 01/24 | | |
| Recruiting | N/A | 450 | RoW | Healthy control specimen collection, Non-Borrmann IV patient specimen collection, Borrmann IV patient specimen collection | First Hospital of China Medical University, Liaoning Cancer Hospital & Institute, The Second Hospital of Shandong University, The General Hospital of Fushun Mining Bureau, The fourth People's Hospital of Changzhou, The First People's Hospital of Jingzhou | Stomach Neoplasms, Gut Microbiota, Metabolomics | 01/24 | 12/25 | | |
